Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monitoring of donepezil concentrations and oxidative stress biomarkers in plasma and cerebrospinal fluid of patients with Alzheimer's disease
2017-003586-94Phase 4Completed
- Sponsor
- Fakultní nemocnice Hradec Králové
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of donepezil in Alzheimer's disease (AD), sponsored by Fakultní nemocnice Hradec Králové. Primary endpoints: Development of sensitive and reproducible assay for donepezil and Monitoring oxidative stress biomarkers and acetylcholinesterase activity. Started Jan 2018; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2017-003586-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003586-94.